Join the Ischemic Stroke group to help and get support from people like you.
Ischemic Stroke News (Page 10)
Related terms: Cerebrovascular Accident (CVA), Stroke, CVA, Cerebrovascular Accident, Stroke, ischemic
Stroke Certification Less Likely in the Most Disadvantaged Communities
TUESDAY, July 30, 2024 – Hospitals located in the most disadvantaged communities have a lower likelihood of adopting any stroke certification, according to a study published online July 25 in JAMA...
Research Confirms Chronic High Blood Pressure's Link to Stroke
WEDNESDAY, July 24, 2024 – Having high blood pressure in adulthood greatly raises the odds for multiple types of stroke, a new study confirms. “Our results suggest that early diagnosis and sustained ...
Race, Insurance Stop Many Hispanics From Getting Post-Stroke Care
THURSDAY, July 18, 2024 – Hispanic people – particularly those without insurance – are less likely to get the additional care needed to recover from a stroke, a new study finds. Hispanic folks are...
Disparities in Post-Acute Stroke Care Depend on Insurance Status
WEDNESDAY, July 17, 2024 – Insurance-dependent racial and ethnic disparities and regional variations are seen in post-acute service utilization after stroke, according to a study published online...
U.S. Stroke Survival Is Improving, But Race Still Plays Role
TUESDAY, July 16, 2024 – There's good news and bad for stroke survival in the United States: New research shows that Americans are now more likely to survive long-term, but that's more true for...
Brilinta Approved in the US to Reduce the Risk of Stroke in Patients with an Acute Ischemic Stroke or High-Risk Transient Ischemic Attack
6 November 2020 – AstraZeneca’s Brilinta (ticagrelor) has been approved in the US to reduce the risk of stroke, a leading cause of disability and death worldwide, in patients with acute ischemic str...
FDA Approves Praluent (alirocumab) to Prevent Heart Attack, Stroke and Unstable Angina Requiring Hospitalization
PARIS and TARRYTOWN, NY – April 26, 2019 – The U.S. Food and Drug Administration (FDA) has approved Praluent (alirocumab) to reduce the risk of heart attack, stroke, and unstable angina requiring hos...
FDA Medwatch Alert: Plavix (clopidogrel): Drug Safety Communication - Long-term Treatment Does Not Change Risk of Death
ISSUE: An FDA review has determined that long-term use of the blood-thinning drug Plavix (clopidogrel) does not increase or decrease overall risk of death in patients with, or at risk for, heart...